Literature DB >> 26116499

CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.

Pablo Penaloza-MacMaster1, Nicholas M Provine1, Eryn Blass1, Dan H Barouch2.   

Abstract

In various models of chronic infections and cancers, blockade of the inhibitory programmed cell death-1 (PD-1) pathway has been shown to be promising at restoring immune function. However, there is not a complete understanding of the factors that influence responsiveness to programmed death-ligand 1 (PD-L1) blockade. In particular, it is currently unclear whether the efficacy of PD-L1 blockade is dependent on the stage of disease. In a model of chronic lymphocytic choriomeningitis virus infection in mice, we show that exhausted CD8 T cells during the late stage of infection are refractory to rescue by PD-L1 blockade. Interestingly, PD-L1 blockade during the late stage of infection resulted in a biased expansion of PD-1(+) CTLA-4(+) regulatory T cells (Tregs) over antiviral CD8 T cells. Although previous studies have shown that Treg ablation can enhance the immune rescue by PD-L1 blockade, this regimen may induce lethal autoimmunity. In this report, we show that PD-L1 blockade together with CD4 T cell depletion effectively rescued deeply exhausted CD8 T cells and enhanced antiviral control during the late stage of chronic infection without any associated mortality. These data demonstrate the pleiotropic effects of anti-PD-L1 therapy on both virus-specific CD8 T cells and Tregs, and suggest a novel strategy for effectively rescuing deeply exhausted CD8 T cells.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26116499      PMCID: PMC4505958          DOI: 10.4049/jimmunol.1403237

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

Review 1.  Natural regulatory T cells in infectious disease.

Authors:  Yasmine Belkaid; Barry T Rouse
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

2.  PD-1 blockade: rescue from a near-death experience.

Authors:  Joseph N Blattman; Philip D Greenberg
Journal:  Nat Immunol       Date:  2006-03       Impact factor: 25.606

3.  Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination.

Authors:  E John Wherry; Joseph N Blattman; Rafi Ahmed
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection.

Authors:  Isabelle Suffia; Stacie K Reckling; Gerson Salay; Yasmine Belkaid
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

5.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.

Authors:  Cheryl L Day; Daniel E Kaufmann; Photini Kiepiela; Julia A Brown; Eshia S Moodley; Sharon Reddy; Elizabeth W Mackey; Joseph D Miller; Alasdair J Leslie; Chantal DePierres; Zenele Mncube; Jaikumar Duraiswamy; Baogong Zhu; Quentin Eichbaum; Marcus Altfeld; E John Wherry; Hoosen M Coovadia; Philip J R Goulder; Paul Klenerman; Rafi Ahmed; Gordon J Freeman; Bruce D Walker
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

6.  Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.

Authors:  Pablo Penaloza-MacMaster; Daniel L Barber; E John Wherry; Nicholas M Provine; Jeffrey E Teigler; Lily Parenteau; Stephen Blackmore; Erica N Borducchi; Rafael A Larocca; Kathleen B Yates; Hao Shen; W Nicholas Haining; Rami Sommerstein; Daniel D Pinschewer; Rafi Ahmed; Dan H Barouch
Journal:  Science       Date:  2015-01-16       Impact factor: 47.728

7.  Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.

Authors:  Jeong M Kim; Jeffrey P Rasmussen; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2006-11-30       Impact factor: 25.606

8.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

9.  Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.

Authors:  Laurence Weiss; Vladimira Donkova-Petrini; Laure Caccavelli; Michèle Balbo; Cédric Carbonneil; Yves Levy
Journal:  Blood       Date:  2004-07-22       Impact factor: 22.113

Review 10.  Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.

Authors:  Gordon J Freeman; E John Wherry; Rafi Ahmed; Arlene H Sharpe
Journal:  J Exp Med       Date:  2006-09-25       Impact factor: 14.307

View more
  20 in total

1.  T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells.

Authors:  Mitra Bhattacharyya; Pablo Penaloza-MacMaster
Journal:  Immunology       Date:  2017-04-18       Impact factor: 7.397

Review 2.  CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway.

Authors:  Pablo Penaloza-MacMaster
Journal:  Immunology       Date:  2017-04-25       Impact factor: 7.397

3.  Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes.

Authors:  Jason M Schenkel; Rebecca H Herbst; David Canner; Amy Li; Michelle Hillman; Sean-Luc Shanahan; Grace Gibbons; Olivia C Smith; Jonathan Y Kim; Peter Westcott; William L Hwang; William A Freed-Pastor; George Eng; Michael S Cuoco; Patricia Rogers; Jin K Park; Megan L Burger; Orit Rozenblatt-Rosen; Le Cong; Kristen E Pauken; Aviv Regev; Tyler Jacks
Journal:  Immunity       Date:  2021-09-16       Impact factor: 43.474

4.  CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection.

Authors:  Rakieb Andargachew; Ryan J Martinez; Elizabeth M Kolawole; Brian D Evavold
Journal:  J Immunol       Date:  2018-05-18       Impact factor: 5.422

Review 5.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

6.  Interrogating Adaptive Immunity Using LCMV.

Authors:  Tanushree Dangi; Young Rock Chung; Nicole Palacio; Pablo Penaloza-MacMaster
Journal:  Curr Protoc Immunol       Date:  2020-09

7.  Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection.

Authors:  Caitlin Bohannon; Ryan Powers; Lakshmipriyadarshini Satyabhama; Ang Cui; Christopher Tipton; Miri Michaeli; Ioanna Skountzou; Robert S Mittler; Steven H Kleinstein; Ramit Mehr; Frances Eun-Yun Lee; Ignacio Sanz; Joshy Jacob
Journal:  Nat Commun       Date:  2016-06-07       Impact factor: 14.919

8.  Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.

Authors:  Leo Swadling; John Halliday; Christabel Kelly; Anthony Brown; Stefania Capone; M Azim Ansari; David Bonsall; Rachel Richardson; Felicity Hartnell; Jane Collier; Virginia Ammendola; Mariarosaria Del Sorbo; Annette Von Delft; Cinzia Traboni; Adrian V S Hill; Stefano Colloca; Alfredo Nicosia; Riccardo Cortese; Paul Klenerman; Antonella Folgori; Eleanor Barnes
Journal:  Vaccines (Basel)       Date:  2016-08-02

9.  A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses.

Authors:  Italia Grenga; Renee N Donahue; Lauren M Lepone; Jacob Richards; Jeffrey Schlom
Journal:  Clin Transl Immunology       Date:  2016-05-20

10.  Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.

Authors:  Hila Ben-Yehuda; Michal Arad; Javier María Peralta Ramos; Efrat Sharon; Giulia Castellani; Shir Ferrera; Liora Cahalon; Sarah Phoebeluc Colaiuta; Tomer-Meir Salame; Michal Schwartz
Journal:  Mol Neurodegener       Date:  2021-06-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.